🔴 Moleculin Biotech is trading 5.5% down today as selling pressure from $9.3M public offering continues

Moleculin Biotech is trading 5.5% down at $0.39 as the stock continues to absorb heavy selling pressure tied to its recently announced $9.3 million public offering, which significantly diluted existing shareholders.

• Shares remain under significant pressure after collapsing from above $2.00 on July 31 following the financing announcement.
• Today’s price action reflects the ongoing digestion of the dilutive offering rather than fresh fundamental news.
• The downward trend persists despite a generally supportive market backdrop for the broader biotech sector.